Neuroprotective role of a novel copper chelator against Aβ42 induced neurotoxicity

International Journal of Alzheimer's Disease

Volumn 2013, Issue , 2013, Pages

  Singh, Sandeep Kumar ^a   Sinha, Priti ^a   Mishra, L ^a   Srikrishna, S ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2, 6 PYRIDINEDICARBOXYLIC ACID,2,6 BIS[2[(4 CARBOXYPHENYL)METHYLENE]HYDRAZIDE]; AMYLOID BETA PROTEIN[1-42]; CHELATING AGENT; CUPROUS ION; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHELATION THERAPY; CONTROLLED STUDY; DROSOPHILA; DRUG SCREENING; EYE DEGENERATION; EYE DISEASE; IN VIVO STUDY; MASS SPECTROMETRY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TISSUE DEGENERATION;

EID: 84885461983     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2013/567128     Document Type: Article

References (37)

1. Faller P., Hureau C., Bioinorganic chemistry of copper and zinc ions coordinated to amyloid- β peptide. Dalton Transactions 2009 7 1080 1094 2-s2.0-59449097016 10.1039/b813398k
2. Hung Y. H., Bush A. I., Cherny R. A., Copper in the brain and Alzheimer's disease. Journal of Biological Inorganic Chemistry 2009 15 61 76
3. Crichton R. R., Dexter D. T., Ward R. J., Metal based neurodegenerative diseases-from molecular mechanisms to therapeutic strategies. Coordination Chemistry Reviews 2008 252 10-11 1189 1199 2-s2.0-41949095459 10.1016/j.ccr.2007.10.019
4. Donnelly P. S., Xiao Z., Wedd A. G., Copper and Alzheimer's disease. Current Opinion in Chemical Biology 2007 11 2 128 133 2-s2.0-34047276442 10.1016/j.cbpa.2007.01.678 (Pubitemid 46546475)
5. Hureau C., Coordination of redox active metal ions to the amyloid precursor protein and to amyloid- β peptides involved in Alzheimer disease-part 1: an overview. Coordination Chemistry Reviews 2012 256 19-20 2164 2174 2-s2.0-84860591474 10.1016/j.ccr.2012.03.037
6. Barnham K. J., McKinstry W. J., Multhaup G., Galatis D., Morton C. J., Curtain C. C., Williamson N. A., White A. R., Hinds M. G., Norton R. S., Beyreuther K., Masters C. L., Parker M. W., Cappai R., Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis. The Journal of Biological Chemistry 2003 278 19 17401 17407 2-s2.0-0037931743 10.1074/jbc.M300629200 (Pubitemid 36799626)
7. Hesse L., Beher D., Masters C. L., Multhaup G., The β A4 amyloid precursor protein binding to copper. FEBS Letters 1994 349 1 109 116 2-s2.0-0028177269 10.1016/0014-5793(94)00658-X
8. White A. R., Multhaup G., Galatis D., McKinstry W. J., Parker M. W., Pipkorn R., Beyreuther K., Masters C. L., Cappai R., Contrasting, speciesdependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein. Journal of Neuroscience 2002 22 2 365 376 (Pubitemid 34049074)
9. Smith D. G., Cappai R., Barnham K. J., The redox chemistry of the Alzheimer's disease amyloid β peptide. Biochimica et Biophysica Acta 2007 1768 8 1976 1990 10.1016/j.bbamem.2007.02.002 (Pubitemid 47125850)
10. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C. L., Beyreuther K., The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 1996 271 5254 1406 1409 2-s2.0-0029935396 (Pubitemid 26089474)
11. Multhaup G., Ruppert T., Schlicksupp A., Hesse L., Beher D., Masters C. L., Beyreuther K., Reactive oxygen species and Alzheimer's disease. Biochemical Pharmacology 1997 54 5 533 539 2-s2.0-0030827975 10.1016/S0006-2952(97)00062-2 (Pubitemid 27405186)
12. Venarucci D., Venarucci V., Vallese A., Battilà L., Casado A., de la Torre R., Fernandez M. E. L., Free radicals: important cause of pathologies refer to ageing. Panminerva Medica 1999 41 335 339 2-s2.0-0033254082
13. Allen R. G., Tresini M., Oxidative stress and gene regulation. Free Radical Biology and Medicine 2000 28 3 463 499 2-s2.0-0033963704 10.1016/S0891-5849(99)00242-7 (Pubitemid 30110662)
14. Butterfield D. A., Reed T., Newman S. F., Sultana R., Roles of amyloid β -peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radical Biology and Medicine 2007 43 5 658 677 2-s2.0-34547102265 10.1016/j.freeradbiomed.2007.05.037 (Pubitemid 47102132)
15. 2 The Journal of Biological Chemistry 2002 277 43 40302 40308 2-s2.0-0037174856 10.1074/jbc.M206428200 (Pubitemid 35215603)
16. Eskici G., Axelsen P. H., Copper and oxidative stress in the pathogenesis of Alzheimer's disease. Biochemistry 2012 51 32 6289 6311 10.1021/bi3006169
17. Hureau C., Faller P., A β -mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease. Biochimie 2009 91 10 1212 1217 2-s2.0-69749106568 10.1016/j.biochi.2009.03.013
18. Barnham K. J., Masters C. L., Bush A. I., Neurodegenerative diseases and oxidative stress. Nature Reviews Drug Discovery 2004 3 205 214 10.1038/nrd1330
19. Lakatos A., Zsigó É., Hollender D., Nagy N. V., Fülöp L., Simon D., Bozsó Z., Kiss T., Two pyridine derivatives as potential Cu(II) and Zn(II) chelators in therapy for Alzheimer's disease. Dalton Transactions 2010 39 5 1302 1315 2-s2.0-76749107569 10.1039/b916366b
20. Green D. E., Bowen M. L., Scott L. E., Storr T., Merkel M., Böhmerle K., Thompson K. H., Patrick B. O., Schugar H. J., Orvig C., In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. Dalton Transactions 2010 39 6 1604 1615 2-s2.0-76749124448 10.1039/b918439b
21. Storr T., Merkel M., Song-Zhao G. X., Scott L. E., Green D. E., Bowen M. L., Thompson K. H., Patrick B. O., Schugar H. J., Orvig C., Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. Journal of the American Chemical Society 2007 129 23 7453 7463 2-s2.0-34347237264 10.1021/ja068965r (Pubitemid 46991735)
22. Wu W. H., Lei P., Liu Q., Hu J., Gunn A. P., Chen M. S., Rui Y. F., Su X. Y., Xie Z. P., Zhao Y. F., Bush A. I., Li Y. M., Sequestration of copper from β -amyloid promotes selective lysis by cyclen-hybrid cleavage agents. The Journal of Biological Chemistry 2008 283 46 31657 31664 2-s2.0-57649130599 10.1074/jbc.M804722200
23. Hureau C., Sasaki I., Gras E., Faller P., Two functions, one molecule: a metal-binding and a targeting moiety to combat Alzheimer's disease. ChemBioChem 2010 11 7 838 953 2-s2.0-77951714977 10.1002/cbic.201000102
24. Perez L. R., Franz K. J., Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease. Dalton Transactions 2010 39 9 2177 2187 2-s2.0-77149144132 10.1039/b919237a
25. Scott L. E., Orvig C., Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. Chemical Reviews 2009 109 10 4885 4910 2-s2.0-70350686620 10.1021/cr9000176
26. - ion. Spectrochimica Acta A 2013 116 286 294 10.1016/j.saa.2013.07.045
27. Wolfe A., Shimer G. H. Jr., Meehan T., Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA. Biochemistry 1987 26 20 6392 6396 2-s2.0-0023618205 (Pubitemid 17155512)
28. Singh M. P., Reddy M. M. K., Mathur N., Saxena D. K., Chowdhuri D. K., Induction of hsp70, hsp60, hsp83 and hsp26 and oxidative stress markers in benzene, toluene and xylene exposed Drosophila melanogaster: role of ROS generation. Toxicology and Applied Pharmacology 2009 235 2 226 243 2-s2.0-60349113650 10.1016/j.taap.2008.12.002
29. Nishikimi M., Rao N. A., Yagi K., The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochemical and Biophysical Research Communications 1972 46 2 849 854 2-s2.0-0015530358
30. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 2-s2.0-0018384650 (Pubitemid 9194347)
31. Wolff T., Preparation of Drosophila eye specimens for scanning electron microscopy. Cold Spring Harbor Protocols 2011 10.1101/pdb.prot066506
32. Citron M., Alzheimer's disease: strategies for disease modification. Nature Reviews Drug Discovery 2010 9 5 387 398
33. Donmez G., Wang D., Cohen D. E., Guarente L., SIRT1 suppresses β -amyloid production by activating the α -secretase gene ADAM10. Cell 2010 142 2 320 332 2-s2.0-77955046461 10.1016/j.cell.2010.06.020
34. Noël S., Perez F., Pedersen J. T., Alies B., Ladeira S., Sayen S., Guillon E., Gras E., Hureau C., A new water-soluble Cu(II) chelator that retrieves Cu from Cu(amyloid- β) species, stops associated ROS production and prevents Cu(II)-induced A β aggregation. Journal of Inorganic Biochemistry 2012 117 322 325 10.1016/j.jinorgbio.2012.05.016
35. Hua H., Münter L., Harmeier A., Georgiev O., Multhaup G., Schaffner W., Toxicity of Alzheimer's disease-associated A β peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability. Biological Chemistry 2011 392 10 919 926 2-s2.0-80052779276 10.1515/BC.2011.084
36. McCord J. M., Keele B. B. Jr., Fridovich I., An enzyme-based theory of obligate anaerobiosis: the physiological function of superoxide dismutase. Proceedings of the National Academy of Sciences of the United States of America 1971 68 5 1024 1027 2-s2.0-0015056379
37. Orr W. C., Sohal R. S., Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 1994 263 5150 1128 1130 2-s2.0-0028220114 (Pubitemid 24105957)